An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees

NCT00686582 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Smallpox

Interventions

BIOLOGICAL: IMVAMUNE
BIOLOGICAL: IMVAMUNE
PROCEDURE: Blood Draw Only

Sponsor

Bavarian Nordic

Collaborators

[object Object]